| 51 |
22451032 | Interleukin-6 and cytochrome-P450, reason for concern? | 2012 Sep |
1 |
| 52 |
22529023 | Statin medication in patients treated with antiepileptic drugs in Norway. | 2012 Aug |
1 |
| 53 |
22912565 | Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. | 2012 |
1 |
| 54 |
23032911 | Paracetamol and simvastatin: a potential interaction resulting in hepatotoxicity. | 2012 |
2 |
| 55 |
21443601 | Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. | 2011 Apr |
1 |
| 56 |
21844990 | Tacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients. | 2011 Jul |
1 |
| 57 |
21883349 | Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma. | 2011 Nov |
1 |
| 58 |
21946898 | Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study. | 2011 Dec |
8 |
| 59 |
22287853 | Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole. | 2011 |
1 |
| 60 |
19802823 | Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy. | 2010 Jan |
4 |
| 61 |
19943026 | [Interactions with antiretroviral drugs]. | 2010 Jan |
1 |
| 62 |
20150526 | Effects of concomitant therapy with diltiazem on the lipid responses to simvastatin in Chinese subjects. | 2010 Oct |
1 |
| 63 |
20203109 | Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation. | 2010 Jun |
2 |
| 64 |
20829626 | Management of dyslipidemia in Cushing's syndrome. | 2010 |
2 |
| 65 |
21045169 | Rhabdomyolysis in a patient receiving high-dose simvastatin after the induction of therapeutic hypothermia. | 2010 Dec |
1 |
| 66 |
21105332 | [Effect of polymorphisms of cytochrome P450 and apolipoprotein E genes on therapeutic efficacy of statins]. | 2010 |
1 |
| 67 |
19206087 | Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. | 2009 Apr |
2 |
| 68 |
19220274 | Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy. | 2009 Feb |
3 |
| 69 |
19429419 | Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. | 2009 May 12 |
1 |
| 70 |
20183988 | [Statins under fire: justified or not?]. | 2009 Dec |
1 |
| 71 |
18213452 | Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms. | 2008 Jul |
2 |
| 72 |
18302447 | Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study. | 2008 |
2 |
| 73 |
18558792 | Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. | 2008 |
4 |
| 74 |
18783297 | General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information. | 2008 |
1 |
| 75 |
17192506 | Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects. | 2007 Jan |
1 |
| 76 |
17304269 | [Interaction risk with statin switch]. | 2007 Feb 15 |
2 |
| 77 |
17381388 | Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. | 2007 Apr |
2 |
| 78 |
17615423 | Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. | 2007 Jul-Aug |
2 |
| 79 |
18220561 | Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis. | 2007 Dec |
1 |
| 80 |
16415122 | In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer. | 2006 Apr |
1 |
| 81 |
16537817 | Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity. | 2006 Apr |
2 |
| 82 |
16580903 | Comparison of midazolam and simvastatin as cytochrome P450 3A probes. | 2006 Apr |
2 |
| 83 |
16581325 | Statin safety and drug interactions: clinical implications. | 2006 Apr 17 |
2 |
| 84 |
16581329 | Statin safety: a systematic review. | 2006 Apr 17 |
4 |
| 85 |
16611111 | Thienopyridines and statins: assessing a potential drug-drug interaction. | 2006 |
1 |
| 86 |
16714062 | Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. | 2006 Oct |
2 |
| 87 |
17178259 | Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. | 2006 Dec |
2 |
| 88 |
15650881 | Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients. | 2005 Feb |
5 |
| 89 |
15679472 | Existence of a clinically relevant interaction between clopidogrel and HMG-CoA reductase inhibitors? Re-evaluating the evidence. | 2005 Feb |
1 |
| 90 |
15811174 | Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis. | 2005 Apr |
1 |
| 91 |
15963098 | Suboptimal choices and dosing of statins at start of therapy. | 2005 Jul |
1 |
| 92 |
16238904 | Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. | 2005 Oct |
1 |
| 93 |
16264203 | Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. | 2005 Nov |
1 |
| 94 |
16321621 | The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. | 2005 Nov |
1 |
| 95 |
12603176 | Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin. | 2003 |
1 |
| 96 |
12817528 | Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide. | 2003 Jun |
1 |
| 97 |
14522569 | Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study. | 2003 Oct |
1 |
| 98 |
14612892 | Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. | 2003 Nov 17 |
2 |
| 99 |
12410059 | Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. | 2002 Sep-Oct |
1 |
| 100 |
12433810 | Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. | 2002 Dec |
1 |